Go Digit General Insurance Ltd. announces an acquisition

The numeric share-swap ratio is not stated in the cited disclosures. The scheme is described as providing Go Digit General Insurance equity shares to Go Digit Infoworks shareholders under a fixed ratio determined through an independent valuation report, with a fairness opinion obtained; however, the available extract does not specify the ratio in an “X shares for every Y shares” format. The issue price of Rs 375.10 per share is not the swap ratio. ^[1]

Equity share-capital impact

The disclosed issuance is for approximately Rs 43 Crores at Rs 375.10 per share. On that basis:

• Implied new shares: approximately 11.46 lakh shares, derived as Rs 43 Crores divided by Rs 375.10 per share. ^[1]
• Post-issue outstanding shares: pre-amalgamation outstanding shares plus approximately 11.46 lakh shares.
• The precise post-issue share count cannot be stated without the pre-issue outstanding share count and the final scheme allotment.
• Paid-up equity share capital would increase by new shares issued × the share’s face value; the face value is not stated in the cited material.

The transaction involves no cash consideration and is therefore primarily a denominator and ownership-structure event. The company has indicated that promoter ownership would rise only marginally, from 72.17% to approximately 72.20% on a fully diluted basis. ^[1]

Pro-forma EPS impact

If:

• `S` = existing outstanding shares;
• `N` = approximately 11.46 lakh new shares; and
• pro-forma earnings are unchanged,

then:

`Pro-forma EPS = pro-forma net profit / (S + N)`

Accordingly, the mechanical EPS dilution would be:

`Dilution = N / (S + N)`

Thus, EPS would decline mechanically because the share denominator increases, unless the amalgamation contributes sufficient incremental earnings or removes costs to offset the additional shares. A numerical pro-forma EPS cannot be calculated from the cited disclosures because the exact swap ratio, final allotment, pre-issue share count and pro-forma earnings are not reported.

The CCI approval is not yet the effective date of the amalgamation; NCLT, IRDAI and shareholder approvals remain outstanding. ^[2]

No specific financial or operating synergy is quantified in the scheme-related disclosure available here. There is no reported estimate for tax savings, annual administrative-cost reduction, headcount savings, duplicated-system rationalisation, incremental profit, cash-flow benefit, EPS accretion, or a synergy realisation timeline.

The disclosure is limited to:

• Structural outcome: Go Digit Infoworks Services, the holding company, is to amalgamate into Go Digit General Insurance, with Digit General as the surviving entity; Infoworks will be dissolved once the Scheme becomes effective. ^{[3] [3]}
• Ownership effect: the collective effective voting interest of Kamesh Goyal and Oben Ventures is expected to reduce to approximately 14.92%. This is an ownership consequence, not a quantified operating synergy. ^[3]
• Regulatory assessment: the CCI found no appreciable adverse effect on competition and cited market shares in the 0–5% range for the relevant businesses. This addresses competition risk, not cost savings or financial benefits. ^[4]

Accordingly, the merger rationale should be read as corporate simplification and elimination of the holding-company layer, rather than as a disclosed cost-synergy or tax-efficiency programme. Any benefits from lower compliance, governance, audit, legal, or inter-company administration costs remain qualitative and unquantified in the cited exchange-filed material.

The CCI approval is not the closing approval. The remaining disclosed conditions are:

• NCLT approval: The first-motion application has been allowed by the NCLT Mumbai Bench, but the final NCLT process/order remains pending. The company must proceed with the subsequent NCLT process for sanction of the Scheme. ^[5]
• Equity shareholder approval: NCLT has directed the company to convene an equity-shareholder meeting to consider and approve the Scheme. ^[5]
• IRDAI approval: The company’s exchange disclosure specifically lists approval from the Insurance Regulatory and Development Authority of India as still required. ^[2]
• Creditor approvals: The cited disclosure refers expressly to shareholders, but does not separately specify creditor approval or a creditor meeting. Whether creditors are required, or are dispensed with under the NCLT directions, is therefore not established by the cited filing extract. ^[2]

Timeline

The NCLT order was uploaded on 13 August 2026 and requires the equity-shareholder meeting to be held within 90 days, implying a meeting deadline of approximately 11 November 2026. The company had also stated that the certified copy of the NCLT order was still awaited. ^[5]

However, no fixed Effective Date is stated in the cited regulatory disclosures. The Effective Date therefore remains dependent on completion of the shareholder process, receipt of IRDAI approval, the final NCLT sanction/order and the associated post-order filings or formalities. The 90-day period is a deadline for convening the shareholder meeting—not a stated merger-completion date. The CCI’s detailed approval order was received on 1 September 2026, following the CCI approval dated 28 July 2026. ^[2]

Analytical implication: The next visible milestone is the shareholder meeting by roughly November 2026; the Effective Date could only be established after the remaining regulatory and NCLT steps are completed, and should not be assumed to coincide with the shareholder vote.